WASHINGTON — Republicans redrew their line in the sand on drug-pricing issues Thursday, with two GOP lawmakers warning forcefully that stripping monopolies from manufacturers would “radically undermine innovation.”

Rep. Devin Nunes (Calif.), the top Republican on the House Ways and Means health subcommittee, and Rep. Kevin Brady (Texas) cast Democratic proposals as big-government industry takeovers in a letter addressed to the subcommittee’s top Democrat — even as other Republicans have hinted at willingness to crack down on monopolies for high-priced drugs.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy